Journal of the Egyptian National Cancer Institute Q3 Unclaimed
Journal of the Egyptian National Cancer Institute is a journal indexed in SJR in Oncology and Cancer Research with an H index of 30. It is an CC BY Journal It has an SJR impact factor of 0,561 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,561.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,561
SJR Impact factor30
H Index44
Total Docs (Last Year)141
Total Docs (3 years)1848
Total Refs273
Total Cites (3 years)139
Citable Docs (3 years)1.71
Cites/Doc (2 years)42.0
Ref/DocOther journals with similar parameters
American Journal of Clinical Oncology Q3
American Journal of Clinical Oncology: Cancer Clinical Trials Q3
Oncology Letters Q3
World Journal of Oncology Q3
Hereditary Cancer in Clinical Practice Q3
Compare this journals
Aims and Scope
Best articles by citations
Bilateral clear cell sarcoma of the kidney
View moreMaspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density
View moreSmall intestinal cancers among adults in an Egyptian district: A clinicopathological study using a population-based cancer registry
View morePrimary ovarian carcinoid: A report of two cases and a decade registry
View moreRole of cyclins A and E in endometrial carcinogenesis in breast cancer patients under tamoxifen treatment
View moreThe pattern of infection and antibiotics use in terminal cancer patients
View moreComparative dosimetric evaluation of three-dimensional conformal and stereotactic radiotherapy for treatment of intracranial tumors
View moreGastric diffuse large B cell lymphoma presenting as paraneoplastic cerebellar degeneration: Case report and review of literature
View moreDJ-1 and androgen receptor immunohistochemical expression in prostatic carcinoma: A possible role in carcinogenesis
View moreGroin recurrence in patients with early vulvar cancer following superficial inguinal node dissection
View moreWITHDRAWN: Molecular classification of colorectal cancer: Current perspectives and controversies
View moreShort course palliative radiotherapy in the management of choroidal metastasis: An effective technique since ages
View moreDiagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions
View moreCCAAT/enhancer binding protein a gene expression in Egyptian patients with acute myeloid leukemia
View morePorocarcinoma scalp with high risk features treated with surgery and adjuvant radiotherapy: A case report and review of literature
View moreComparative study between the effect of methotrexate and valproic acid on solid Ehrlich tumour
View moreRadiation induced depigmentation disorder in two patients with breast cancer: Exploring a rare accompaniment
View moreE-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions
View moreGemcitabine-oxaliplatin (GEMOX) for epithelial ovarian cancer patients resistant to platinum-based chemotherapy
View moreThe KRAS StripAssay for detection of KRAS mutation in Egyptian patients with colorectal cancer (CRC): A pilot study
View moreAngiomyolipoma of the kidney: Clinicopathological and immunohistochemical study
View moreAdhesion molecules expression in CLL: Potential impact on clinical and hematological parameters
View moreImpact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer
View moreIntegrin-Linked Kinase, Snail and Multidrug Resistance Protein 1: Three concordant players in the progression of non-small cell lung cancer
View more
Comments